These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25239189)

  • 61. Pathological features of FTLD-FUS in a Japanese population: analyses of nine cases.
    Kobayashi Z; Kawakami I; Arai T; Yokota O; Tsuchiya K; Kondo H; Shimomura Y; Haga C; Aoki N; Hasegawa M; Hosokawa M; Oshima K; Niizato K; Ishizu H; Terada S; Onaya M; Ikeda M; Oyanagi K; Nakano I; Murayama S; Akiyama H; Mizusawa H
    J Neurol Sci; 2013 Dec; 335(1-2):89-95. PubMed ID: 24050818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study.
    Hatanpaa KJ; Bigio EH; Cairns NJ; Womack KB; Weintraub S; Morris JC; Foong C; Xiao G; Hladik C; Mantanona TY; White CL
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):271-9. PubMed ID: 18379440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes.
    Dean PM; Smith GE; Parisi JE; Dickson DW; Petersen RC; Josephs KA
    J Clin Neurosci; 2013 Dec; 20(12):1737-41. PubMed ID: 24012243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating.
    Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2011 Aug; 31(4):401-4. PubMed ID: 21175864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo.
    Porta S; Xu Y; Restrepo CR; Kwong LK; Zhang B; Brown HJ; Lee EB; Trojanowski JQ; Lee VM
    Nat Commun; 2018 Oct; 9(1):4220. PubMed ID: 30310141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
    Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM
    Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
    Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
    J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia.
    Kovacs GG; van der Zee J; Hort J; Kristoferitsch W; Leitha T; Höftberger R; Ströbel T; Van Broeckhoven C; Matej R
    Neuropathology; 2016 Feb; 36(1):27-38. PubMed ID: 26234378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions.
    Farmer JG; Crain BJ; Harris BT; Turner RS
    Neurocase; 2013; 19(1):67-75. PubMed ID: 22506890
    [TBL] [Abstract][Full Text] [Related]  

  • 73. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.
    Mori K; Lammich S; Mackenzie IR; Forné I; Zilow S; Kretzschmar H; Edbauer D; Janssens J; Kleinberger G; Cruts M; Herms J; Neumann M; Van Broeckhoven C; Arzberger T; Haass C
    Acta Neuropathol; 2013 Mar; 125(3):413-23. PubMed ID: 23381195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Cairns NJ
    Neurol Sci; 2011 Aug; 32(4):653-9. PubMed ID: 21647631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.
    Josephs KA; Stroh A; Dugger B; Dickson DW
    Acta Neuropathol; 2009 Sep; 118(3):349-58. PubMed ID: 19455346
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.
    Schwab C; Arai T; Hasegawa M; Yu S; McGeer PL
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1159-65. PubMed ID: 19018245
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions].
    Yokota O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1018-21. PubMed ID: 21921551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
    Bosque PJ; Boyer PJ; Mishra P
    PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.